In summary, our results provide novel insights into the mechanisms by which CAAs promote malignant progression of breast cancer and afford a promising choice for intervention of invasive breast cancer by targeting CAA-derived G-CSF. The gene discussed is CSF3; the disease is breast carcinoma.